---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013108"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:44:25.235922+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Processa shareholders approve 10x increase in authorized shares, reverse split up to 1:50

## Summary
- Approved increase of authorized common shares from 100M to 1B (13.7M for, 3.0M against).
- Approved reverse stock split at ratio 1:2 to 1:50, effective by Dec 31, 2026 (13.9M for).
- Approved amendment to 2019 Omnibus Incentive Plan to increase shares available (13.6M for).
- Adjournment proposal approved but not needed due to sufficient votes on substantive proposals.

## SEC filing metadata
- accession: 0001493152-25-013108
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315225013108/0001493152-25-013108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315225013108/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013108
- JSON: https://secwatch.observer/filing/0001493152-25-013108.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.